ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
TELIX PHARMACEUTICALS LTD
9.850
-0.280
-2.76%
成交量:
300.23萬
成交額:
2,931.28萬
市值:
33.36億
市盈率:
162.11
高:
10.000
開:
10.000
低:
9.590
收:
10.130
52周最高:
31.970
52周最低:
9.590
股本:
3.39億
流通股本:
2.75億
量比:
1.08
換手率:
1.09%
股息:
- -
股息率:
- -
每股收益(TTM):
0.061
每股收益(LYR):
0.206
淨資產收益率:
3.14%
總資產收益率:
2.08%
市淨率:
5.55
市盈率(LYR):
47.80
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
Telix實現2025財年營收8.04億美元(12億澳元)目標,Gozellix上市加速增長
美股速递
·
01/20
BUZZ-澳大利亞泰利克斯製藥公司因中國接受新藥申請而上漲
路透中文
·
01/20
精準醫療投資組合更新:Illuccix中國三期研究及Tlx101-Cdx和Tlx250-Cdx FDA重新提交
美股速递
·
2025/12/22
Thor Medical與Telix Pharmaceuticals簽署戰略供應協議,提供銩228
投资观察
·
2025/11/20
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/TLX.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":9.85,"timestamp":1770354720000,"preClose":10.13,"halted":0,"volume":3002322,"delay":0,"changeRate":-0.027640671273445324,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":275410996,"shares":338721355,"eps":0.060783341031035984,"marketStatus":"休市中","change":-0.28,"latestTime":"02-06 16:12:00 AEDT","open":10,"high":10,"low":9.59,"amount":29312805,"amplitude":0.040474,"askPrice":9.88,"askSize":633,"bidPrice":9.8,"bidSize":300,"shortable":3,"etf":0,"ttmEps":0.060783341031035984,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1770591600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":10.13,"openAndCloseTimeList":[[1770332400000,1770354000000]],"volumeRatio":1.0760365130780325,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":275410996,"roa":"2.08%","roe":"3.14%","lyrEps":0.206058,"volumeRatio":1.0760365130780325,"shares":338721355,"dividePrice":0,"high":10,"amplitude":0.040474,"preClose":10.13,"low":9.59,"week52Low":9.59,"pbRate":"5.55","psRate":"3.52","week52High":31.97,"institutionHeld":0,"latestPrice":9.85,"committee":-0.356913,"eps":0.06076281270261989,"divideRate":0,"volume":3002322,"delay":0,"ttmEps":0.06076281270261989,"open":10,"prevYearClose":11.2,"prevWeekClose":10.55,"prevMonthClose":10.55,"prevQuarterClose":11.2,"fiveDayClose":10.55,"twentyDayClose":11.33,"sixtyDayClose":15.32,"earningDate":1771430400000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771455600000,"name":null,"time":"","dateTimestamp":1771419600000,"actualEps":null},{"date":"2026-01-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1768777200000,"name":null,"time":"","dateTimestamp":1768741200000,"actualEps":null},{"date":"2025-08-21","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null},{"date":"2024-08-22","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724284800000,"name":null,"time":"","dateTimestamp":1724248800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1167408007","title":"Telix實現2025財年營收8.04億美元(12億澳元)目標,Gozellix上市加速增長","url":"https://stock-news.laohu8.com/highlight/detail?id=1167408007","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167408007?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 20:07","pubTimestamp":1768910869,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals Ltd宣布达成2025财年业绩指引,实现营收8.04亿美元。公司同时推出新型放射性药物Gozellix,标志着其肿瘤靶向治疗产品线的重大拓展。这一突破性进展不仅巩固了Telix在核医学领域的领先地位,更为全球癌症患者提供了更精准的治疗选择。随着Gozellix的正式商业化,Telix将同步启动全球市场推广计划。Telix首席执行官表示,此次双里程碑的达成得益于公司持续的技术创新与全球化战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"gpt_icon":0},{"id":"2604055151","title":"BUZZ-澳大利亞泰利克斯製藥公司因中國接受新藥申請而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2604055151","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604055151?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 08:39","pubTimestamp":1768869597,"startTime":"0","endTime":"0","summary":"1月20日 - ** 澳大利亚泰利克斯制药公司TLX.AX股价上涨6.3%至11.99澳元,创下近两个月来最大盘中涨幅。(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4S3YL01L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","00512","TLX.AU","BK4157","BK1191","TNLX"],"gpt_icon":0},{"id":"1170607192","title":"精準醫療投資組合更新:Illuccix中國三期研究及Tlx101-Cdx和Tlx250-Cdx FDA重新提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1170607192","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170607192?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 05:40","pubTimestamp":1766353209,"startTime":"0","endTime":"0","summary":"精准医疗投资组合更新:Illuccix中国三期研究及Tlx101-Cdx和Tlx250-Cdx FDA重新提交","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"gpt_icon":0},{"id":"1108683421","title":"Thor Medical與Telix Pharmaceuticals簽署戰略供應協議,提供銩228","url":"https://stock-news.laohu8.com/highlight/detail?id=1108683421","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108683421?lang=zh_tw&edition=fundamental","pubTime":"2025-11-20 00:51","pubTimestamp":1763571104,"startTime":"0","endTime":"0","summary":"11月6日 - Thor Medical ASA宣布与Telix Pharmaceuticals达成战略供应协议,将在未来五年内向Telix供应铥228。从2026年第三季度起,铥228将从AlphaOne基地开始供给。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","BK7067"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TLX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}